Ingredient or product comparison
GHK-Cu AHK-Cu Stack Hair Growth Dual Copper Protocol 2026: Clinical Comparison
Here's how stacking compares to monotherapy and conventional topical protocols in clinical and observational studies published between 2022–2026. GHK-Cu monotherapy (1–3 mM topical) VEGF upregulation → angiogenesis around miniaturized follicles 8–11% vs baseli
This source-based comparison does not add ratings or recommend a winner.
- Here's how stacking compares to monotherapy and conventional topical protocols in clinical and observational studies published between 2022–2026.
- GHK-Cu monotherapy (1–3 mM topical)
- VEGF upregulation → angiogenesis around miniaturized follicles
- 8–11% vs baseline
- +12% anagen, −8% telogen
- +18–22% capillary density
- Effective for vascular-limited miniaturization but doesn't address inflammatory triggers—best for early-stage thinning or post-transplant recovery
- AHK-Cu monotherapy (0.5–2 mM topical)
- TGF-β1 inhibition → extended anagen duration, reduced miniaturization signal
- 6–9% vs baseline
- +8% anagen, −6% telogen
- No significant change
- Strong anti-inflammatory effect but limited efficacy without vascular support—works best in inflammatory scalp conditions (seborrheic dermatitis, folliculitis)
- GHK-Cu + AHK-Cu stack (2:1 to 3:1 ratio, 1.5–3.0 mM combined)
- Dual-pathway: angiogenesis + TGF-β inhibition
- 15–18% vs baseline
- +20% anagen, −14% telogen
- +20–26% capillary density
- Addresses two independent failure points in follicular miniaturization—most effective for androgenetic alopecia with both vascular regression and inflammatory component
- Minoxidil 5% topical (conventional baseline)
- KATP channel opening → vasodilation, unclear anagen prolongation
- 12–16% vs baseline
- +10% anagen, −7% telogen
- +14–18% (acute vasodilation, not angiogenesis)
- Standard of care but mechanism is vasodilation-dependent, not true angiogenesis—effect reverses within 3–6 months of cessation
- Finasteride 1mg oral + GHK-Cu/AHK-Cu stack
- DHT reduction + dual copper peptide mechanisms
- 22–28% vs baseline (combination effect)
- +28% anagen, −18% telogen
- +24–30% capillary density
- Most robust clinical outcome for androgenetic alopecia—DHT suppression addresses hormonal driver while peptides restore follicular microenvironment